Huadong Medicine Co., Ltd reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 10,114.53 million compared to CNY 8,932.58 million a year ago. Revenue was CNY 10,114.53 million compared to CNY 8,932.58 million a year ago.

Net income was CNY 755.28 million compared to CNY 704.36 million a year ago. Basic earnings per share from continuing operations was CNY 0.4316 compared to CNY 0.4025 a year ago. Diluted earnings per share from continuing operations was CNY 0.4315 compared to CNY 0.4025 a year ago.